Health Care

Filter By:

Type

Fellow

Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

Featured

Dim Lights, Big City

by Niall Fergusonvia Boston Globe
Monday, May 18, 2020

Nothing illustrates with shocking clarity the perils of big city life than the coronavirus pandemic.

 
 

The Market Impacts of Pharmaceutical Product Patents in Developing Countries

by Mark Duggan, Craig Garthwaite, Aparajita Goyalvia IP2 Working Paper Series
Wednesday, July 1, 2015

In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered dataset of molecule-linked patents issued by the Indian patent office. 

In the NewsBlank Section (Placeholder)

John Cochrane: COVID 19 And Re-Opening The Economy

mentioning John H. Cochranevia Bendheim Center for Finance
Monday, May 18, 2020

On Monday, May 18, at 12:30 PM ET, John Cochrane will join the Princeton Bendheim Center for Finance for a webinar on re-opening the economy after COVID-19. Cochrane is a Senior Fellow at the Hoover Institution at Stanford University and author of The Grumpy Economist blog.

In the News

'Failure To Educate The Public': Stanford University Doctor Outlines 'Gross Failure In Policy' On Reopening States

quoting Scott W. Atlasvia The Washington Examiner
Monday, May 18, 2020

A doctor at Stanford University made the argument for reopening the country, calling for a “design of sound public policy” that involves “more than a single-minded focus on stopping COVID-19 at all costs.”

Analysis and Commentary

Lanhee Chen: The Key Piece For Recovery: School

by Lanhee J. Chenvia Townhall Review
Monday, May 18, 2020

College students should be returning to campus this fall.

Featured

Adding To Dr. Fauci's Diagnosis: The Critical Case For Ending Our Shutdown

by Scott W. Atlasvia The Hill
Monday, May 18, 2020

By now, everyone recognizes Dr. Anthony Fauci. The director of the National Institute of Allergy and Infectious Diseases is one of the most cited immunology researchers of all time and unquestionably one of the most acclaimed. As specified in his own bio, his deep expertise is in research of immune-mediated and infectious disease, particularly their basic mechanisms and treatments.

FeaturedBlank Section (Placeholder)

WHO Reform – Investigate Coronavirus Response And Demand These Changes At Annual Meeting

by Lanhee J. Chenvia Fox News
Sunday, May 17, 2020

The World Health Organization botched its response to the novel coronavirus. It legitimized China’s early and misleading claims about the disease, which set back the initial response to the virus in other countries, including the United States.

Analysis and Commentary

Searching On Foot For My White Whale

by Tunku Varadarajanvia The Washington Post
Sunday, May 17, 2020

Even amid lockdown, an empty Brooklyn street proves to be an elusive quarry.

In the NewsBlank Section (Placeholder)

Warp It Up

cited Victor Davis Hansonvia Powerline
Saturday, May 16, 2020

In his May 14 column “Losing our fears, in war and plague,” Victor Davis Hanson recalls the monumental industrial effort that backed our effort to win World War II. Arthur Herman wrote the book on the subject. I thought of Victor’s column and Herman’s book when President Trump announced the ambitious plan to develop a COVID-19 vaccine and manufacture hundreds of millions of doses by the end of 2020.

Interviews

Dr. Scott Atlas Discusses Policies To Establish Herd Immunity

interview with Scott W. Atlasvia Fox News
Saturday, May 16, 2020

Hoover Institution fellow Scott Atlas discusses the lockdowns and how to reopen the economy now.

Pages

Health Care Policy Working Group


The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.